home / stock / bsem / bsem news

BSEM News and Press, BioStem Technologies Inc

Stock Information
Company Name: BioStem Technologies Inc
Stock Symbol: BSEM
Market: OTC
Website: biostemtechnologies.com
Menu
Get BSEM Alerts

News, Short Squeeze, Breakout and More Instantly...
BSEM - BioStem Technologies Publicly Files Form 10 Registration Statement with the Securities and Exchange Commission

POMPANO BEACH, Fla., July 10, 2026 (GLOBE NEWSWIRE) -- BioStem Technologies Inc. (OTC: BSEM) (“BioStem” or the “Company”), a leading regenerative medicine company focused on the development, manufacturing, and commercialization of perinatal tissue allograft products,...
BSEM - BioStem Technologies gains four U.S. design patents for placental allograft technology

2026-07-08 08:49:12 ET More on BioStem Technologies BioStem Technologies, Inc. (BSEM) Q1 2026 Earnings Call Transcript BioStem Technologies prices $2.5M private placement Seeking Alpha’s Quant Rating on BioStem Technologies Historical earnings data for...

BSEM - BioStem Technologies Announces Issuance of Four U.S. Design Patents Covering Fenestrated Human Placental Allograft Technologies

Company Continues to Expand Intellectual Property Portfolio Supporting Advanced Placental Allograft Innovation POMPANO BEACH, FL / ACCESS Newswire / July 8, 2026 / BioStem Technologies , Inc. (OTCID:BSEM), a leading regenerative medicine company focused on the development, manufacturing,...

BSEM - BioStem Technologies to Present at the Planet MicroCap Las Vegas 2026 Conference

POMPANO BEACH, Fla., June 10, 2026 (GLOBE NEWSWIRE) -- BioStem Technologies Inc. (OTC: BSEM), a leading regenerative medicine company focused on the development, manufacturing, and commercialization of perinatal tissue allograft products, today announced that Company management will present at ...
BSEM - BioStem Technologies Announces Appointment of Three New Members to its Board of Directors

POMPANO BEACH, Fla., June 09, 2026 (GLOBE NEWSWIRE) -- BioStem Technologies Inc. (OTC: BSEM), a leading regenerative medicine company focused on the development, manufacturing, and commercialization of perinatal tissue allograft products, today announced the appointment of Mark Glickman, Steven...

BSEM - BioStem Technologies prices $2.5M private placement

2026-05-22 07:54:04 ET More on BioStem Technologies BioStem Technologies, Inc. (BSEM) Q1 2026 Earnings Call Transcript BioStem Technologies, Inc. (BSEM) Q4 2025 Earnings Call Transcript BioStem Technologies, Inc. 2025 Q4 - Results - Earnings Call Presentation ...

BSEM - BioStem Technologies Announces $2.5 Million Private Placement Financing with its First Institutional Investor

POMPANO BEACH, Fla., May 22, 2026 (GLOBE NEWSWIRE) -- BioStem Technologies Inc. (OTC: BSEM), a leading regenerative medicine company focused on the development, manufacturing, and commercialization of perinatal tissue allograft products, today announced it has entered into a securities purchase ...
BSEM - BioStem Technologies Announces Notice of Allowance for Four U.S. Design Patent Applications Covering Fenestrated Human Placental Allografts and One European Patent

Pompano Beach, FL, May 20, 2026 (GLOBE NEWSWIRE) -- BioStem Technologies®, a leading regenerative medicine company focused on developing and commercializing placental-derived biologics, today announced that the United States Patent and Trademark Office (USPTO) has issued Notices of Allowance...

BSEM - Expected earnings - BioStem Technologies Inc

BioStem Technologies Inc (BSEM) is expected to report $-0.28 for Q1 2026

BSEM - BioStem Technologies, Inc. (BSEM) Q1 2026 Earnings Call Transcript

2026-05-14 19:20:45 ET BioStem Technologies, Inc. (BSEM) Q1 2026 Earnings Call May 14, 2026 4:30 PM EDT... Read the full article on Seeking Alpha For further details see: BioStem Technologies, Inc. (BSEM) Q1 2026 Earnings Call Transcript
Next 10